Nathaniel S. Treister: Oral chronic graft-versus-host disease

In his talk on oral chronic graft-versus-host disease (cGVHD), Nathaniel S. Treister discusses the complexities and challenges of diagnosing and managing this condition. He highlights the impact of cGVHD on oral health, emphasizing symptoms such as mucosal dryness, pain, and difficulty in eating. Treister explores current treatment strategies, including systemic therapies and local interventions, and underscores the importance of multidisciplinary care in improving patient outcomes. He also addresses ongoing research aimed at better understanding the pathophysiology of cGVHD and developing more effective treatments.

SPEAKER: Dr. Nathaniel S. Treister DMD, DMSc is Chief of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital and Clinical Director of Oral Medicine and Oral Oncology at the Dana-Farber/Brigham and Women's Cancer Center in Boston, Massachusetts. Dr. Treister earned his DMD from the University of Pennsylvania School of Dental Medicine and subsequently completed his Oral Medicine and Oral Biology training at the Harvard School of Dental Medicine, where he is an Associate Professor of Oral Medicine in the Department of Oral Medicine, Infection and Immunity. He is board certified in Oral Medicine and practices at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Boston Children’s Hospital, and Dartmouth-Hitchcock Medical Center, with special interest in oral mucosal diseases, salivary gland diseases, orofacial pain disorders, and oral complications in cancer patients. He has published extensively in the field of oral medicine with an emphasis on oral complications of allogeneic hematopoietic cell transplantation and oral graft-versus-host disease, and is a past president of the American Academy of Oral Medicine. He is co-principal investigator of an NIH R01 grant entitled “Long Term Oral Health Outcomes in the Chronic GVHD Consortium” and serves as site principal investigator for an NIH U01 grant entitled “Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients”.

ONLINE LIVE EVENT

San Francisco: Monday, May 19, 2025 at 4:00 pm

Mexico City: Monday, May 19, 2025 at 5:00 pm

New York: Monday, May 19, 2025 at 7:00 pm

Rio de Janeiro: Monday, May 19, 2025 at 8:00 pm

London: Tuesday, May 20, 2025 at 12:00 midnight

Berlin: Tuesday, May 20, 2025 at 1:00 am

Johannesburg: Tuesday, May 20, 2025 at 1:00 am

Cairo: Tuesday, May 20, 2025 at 2:00 am

Dubai: Tuesday, May 20, 2025 at 3:00 am

Islamabad: Tuesday, May 20, 2025 at 4:00 am

New Delhi: Tuesday, May 20, 2025 at 4:30 am

Manila: Tuesday, May 20, 2025 at 7:00 am

LANGUAGE: The event language is english.